Cargando…
Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?
Autores principales: | Giannis, Dimitrios, Douketis, James D., Spyropoulos, Alex C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580837/ https://www.ncbi.nlm.nih.gov/pubmed/34799234 http://dx.doi.org/10.1016/j.ejim.2021.11.003 |
Ejemplares similares
-
Clearing the Air over the London Fog
por: Dooley, E
Publicado: (2002) -
Obesity Surgery and Cancer: What Are the Unanswered Questions?
por: Castagneto-Gissey, Lidia, et al.
Publicado: (2020) -
The Effect of Metabolic Surgery on the Complications of Diabetes: What Are the Unanswered Questions?
por: Neff, Karl J., et al.
Publicado: (2020) -
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question
por: Basile, Vittoria, et al.
Publicado: (2021) -
Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later
por: Eggimann, Philippe, et al.
Publicado: (2014)